Follow
Pramil Tiwari
Title
Cited by
Cited by
Year
Prevalence & determinants of depression in type 2 diabetes patients in a tertiary care centre
A Raval, E Dhanaraj, A Bhansali, S Grover, P Tiwari
Indian Journal of Medical Research 132 (2), 195-200, 2010
2822010
Type 2 diabetes and risk of prostate cancer: a meta-analysis of observational studies
D Bansal, A Bhansali, G Kapil, K Undela, P Tiwari
Prostate cancer and prostatic diseases 16 (2), 151-158, 2013
2332013
Anti-counterfeit technologies: a pharmaceutical industry perspective
D Bansal, S Malla, K Gudala, P Tiwari
Scientia pharmaceutica 81 (1), 1, 2013
2032013
Adverse drug reactions & their risk factors among Indian ambulatory elderly patients
Mandavi, S D'Cruz, A Sachdev, P Tiwari
The Indian journal of medical research 136 (3), 404, 2012
862012
Medication prescribing errors in a public teaching hospital in India: A prospective study
S Pote, P Tiwari, S D'cruz
Pharmacy Practice (Internet) 5 (1), 17-20, 2007
802007
Prescription pattern of antihypertensive agents in T2DM patients visiting tertiary care centre in North India
E Dhanaraj, A Raval, R Yadav, A Bhansali, P Tiwari
International journal of hypertension 2012 (1), 520915, 2012
712012
Prevalence and assessment of factors contributing to adverse drug reactions in wards of a tertiary care hospital, India
DB Haile, W Ayen, P Tiwari
Ethiop J Health Sci 23, 39-48, 2013
692013
Risk factors and complications of type 2 diabetes in Asians
R Yadav, P Tiwari, E Dhanaraj
Crips 9 (2), 8-12, 2008
602008
Prevalence of depression and its associated factors among patients of chronic kidney disease in a public tertiary care hospital in India: A cross-sectional study
R Ahlawat, P Tiwari, S D'Cruz
Saudi Journal of Kidney Diseases and Transplantation 29 (5), 1165-1173, 2018
592018
Drug use pattern in children at a teaching hospital.
S Dimri, P Tiwari, S Basu, VR Parmar
Indian pediatrics 46 (2), 2009
582009
Immunomodulator products from Ayurveda: current status and future perspectives
CK Katiyar, NB Brindavanam, P Tiwari, DBA Narayana
Immunomodulation. Narosa Publishing House, New Delhi, India, 123, 1997
571997
Insulin-related lipohypertrophy: lipogenic action or tissue trauma?
A Barola, P Tiwari, A Bhansali, S Grover, D Dayal
Frontiers in Endocrinology 9, 638, 2018
432018
Drug-drug interactions and their predictors: Results from Indian elderly inpatients
M Kashyap, S D’Cruz, A Sachdev, P Tiwari
Pharmacy practice 11 (4), 191, 2013
422013
Predictors of metabolic syndrome in Asian north Indians with newly detected type 2 diabetes
E Dhanaraj, A Bhansali, S Jaggi, P Dutta, S Jain, P Tiwari, P Ramarao
Indian Journal of Medical Research 129 (5), 506-514, 2009
402009
Prevalence and determinants of use of potentially inappropriate medications in elderly inpatients: a prospective study in a tertiary healthcare setting
K Undela, D Bansal, S D'Cruz, A Sachdev, P Tiwari
Geriatrics & gerontology international 14 (2), 251-258, 2014
392014
Evaluation of the rationality of some FDCs: Focus on antihypertensive drugs
J Panda, P Tiwari, R Uppal
Indian Journal of Pharmaceutical Sciences 68 (5), 649, 2006
392006
Prevalence and predictors of medication non-adherence in patients of chronic kidney disease: evidence from a cross sectional study
R Ahlawat, P Tiwari, S D’Cruz
J Pharma Care Health Sys 3 (152), 2376-0419, 2016
342016
Measurement of adult antimicrobial drug use in tertiary care hospital using defined daily dose and days of therapy
D Bansal, S Mangla, K Undela, K Gudala, S D’Cruz, A Sachdev, P Tiwari
Indian journal of pharmaceutical sciences 76 (3), 211, 2014
342014
Assessment of costs associated with hospital-acquired infections in a private tertiary care hospital in India
P Tiwari, M Rohit
Value in Health regional issues 2 (1), 87-91, 2013
322013
Direct cost for treating chronic kidney disease at an outpatient setting of a tertiary hospital: evidence from a cross-sectional study
R Ahlawat, P Tiwari, S D’Cruz
Value in health regional issues 12, 36-40, 2017
312017
The system can't perform the operation now. Try again later.
Articles 1–20